XDx

XDx

Transforming Transplant Patient Care.

Other | Northern America | Health Improvement |

 

Overview

CareDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. The company has commercialized AlloMap®, a gene expression test that aids clinicians in identifying heart transplant patients with stable graft function who have a low probability of moderate/severe acute cellular rejection. CareDx is also pursuing the development of additional products for transplant monitoring using a variety of technologies, including AlloSure, its next-generation sequencing–based test, to detect donor-derived cell-free DNA after transplantation.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

3260 Bayshore Blvd.
Brisbane, California 94005
United States of America



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Twitter

Tweet from AlloMap: I can't believe it is already time for the Closing Ceremony. This week has flown by! #TGA16CLE https://t.co/2KA5IwWKwF Posted Wed Jun 15 10:22 pm

Tweet from AlloMap: Everyone ready for the beach party? We will see you there! #TGA16CLE https://t.co/f5t7axObc7 Posted Tue Jun 14 9:02 pm

Tweet from AlloMap: Happening now: bocce and bowling! #TGA16CLE https://t.co/pPDv93Lyc3 Posted Tue Jun 14 6:04 pm

Tweet from AlloMap: The latest on the DART trial and AlloSure in kidney transplant. A great way to start the week! https://t.co/H7vPK0QqkD Posted Tue Jun 14 1:20 am

Tweet from AlloMap: Getting ready to celebrate those that gave the gift of life. #donatelife #TGA16CLE Posted Sun Jun 12 8:49 pm

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.